| Financial Year |
March 31 2023 |
| Monetary Funds |
663,489,075.81 |
| Held-for-trading Financial Assets |
388,310,047.30 |
| Notes Receivable |
70,192,172.01 |
| Accounts Receivable |
139,269,892.69 |
| Advances to Suppliers |
52,233,862.36 |
| Other Receivables |
56,702,568.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
242,867,690.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,674,227.12 |
| Total Current Assets |
1,772,319,524.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,614,804,377.53 |
| Investment Properties |
-- |
| Fixed Assetes |
475,403,961.30 |
| Under-construction Projects |
9,563,115.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,681,730.85 |
| R&D expenses |
-- |
| Goodwill |
2,064,864.17 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
24,448,081.30 |
| Other Non-Current Assets |
2,574,193.60 |
| Sub-Total of Non-Current Assets |
4,804,885,170.05 |
| Total Assets |
6,577,204,694.50 |
| Short-Term Loans |
1,219,822,853.86 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
81,799,248.89 |
| Accounts Received In Advance |
3,950,233.80 |
| Employee Compensation Payable |
13,906,271.48 |
| Taxes Payable |
19,603,389.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,081,203.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
41,657,885.91 |
| Sub-Total of Current Liabilities |
1,465,347,957.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
37,665,069.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
37,665,069.73 |
| Total Liabilities |
1,503,013,026.99 |
| Paid-In Capital(Or Share Stock) |
886,012,887.00 |
| Capital Surplus |
391,063,918.14 |
| Surplus Reserve |
425,337,706.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,388,585,738.80 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,074,191,667.51 |
| Owner's Equity（Stockholder's Equity） |
5,074,191,667.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,577,204,694.50 |
